About Capillary Biomedical
Capillary Biomedical is a Healthcare company based in Irvine (United States) founded in 2014, and was acquired by Tandem Diabetes in July 2022. Minimally invasive implants for continuous glucose monitoring are provided. It operates in the Healthcare and Technology sectors. Capillary Biomedical has raised $3 million across 4 funding rounds from investors including Tandem Diabetes, HHS and Pasadena Angels. The company has 1,922 employees. The company was acqui-hired. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Diabetes Monitoring. Its competitors include Dexcom, Livongo and Bigfoot Biomedical; 3 of its 3 listed competitors have raised funding.
Company details
Capillary Biomedical was founded in 2014 and is based in Irvine, United States. The company operates in the biomedical sector, focusing on devices for diabetes management. A small implant is placed under the abdominal skin through an outpatient procedure, where glucose levels in interstitial fluid are measured optically using infrared spectrometry. Data is transmitted wirelessly to external receivers, mobile devices, or insulin pumps, allowing real-time monitoring of glucose trends.
- Headquarters Irvine, United States
- Employees 1,922
- Stage Acquired
- SectorsHealthcareTechnology
- Website capillarybio.com
- Social LinkedIn
- Acquired by Tandem Diabetes (Jul 2022)
- Total Equity Funding$3M (USD)
in 4 rounds
- Latest Funding Round$1.5M (USD), Debt – Conventional
Oct 2020
- InvestorsTandem Diabetes
& 9 more
- Employee Count1,922
- Acquired byTandem Diabetes
(Jul 2022)
Funding Insights of Capillary Biomedical
Capillary Biomedical has successfully raised a total of $3M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.5 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 4
- Last Round Debt – Conventional — $1.5M
- First Round $100,000
(May 2014)
- Investors Count 9
All 4 funding rounds of Capillary Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $1.5M | Debt – Conventional | – | – | |
| Aug 2018 | $2.9M | Seed | – | Cove Fund | |
| Sep 2016 | $2.02M | Grant | – | – | |
| May 2014 | $100,000 | Seed | – | – | – |
10 investors in total: 10 institutional.
Investors in Capillary Biomedical
Capillary Biomedical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Tandem Diabetes, HHS and Pasadena Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A charitable trust focused on healthcare and research funding. | helmsleytrust.org | New York, United States | ||
Seed-stage venture capital funding is provided by Cove Fund. | 2021 | covefund.com | Irvine, United States | |
Angel investors are matched with high-growth SMEs across sectors. | angelgroups.co.uk | Barnsley, United Kingdom | ||
Angel Network for companies based in Southern California | techcoastangels.com | Los Angeles, United States | ||
Early-stage technology startups are funded by New York Angels network. | newyorkangels.com | New York, United States | ||
Seed stage investments are made in life sciences and healthcare. | 2010 | massmedangels.com | Boston, United States | |
Investments are facilitated by Pasadena Angels in Southern California startups. | 2000 | pasadenaangels.com | Altadena, United States | |
| hbsalumniangels.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | tandemdiabetes.com | San Diego, United States |
Investor details for Capillary Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Capillary Biomedical
251 people are tracked at Capillary Biomedical (79 in leadership, 7 in board & advisors, 165 in team); the tracked headcount is 1,922.
| Name | Role | Group |
|---|---|---|
Dave Nuttall | VP, Finance | Leadership |
John F. Sheridan | President & CEO | Leadership |
Peter Rossiter | VP, Information Technology | Leadership |
Julia Kensick | VP, Quality | Leadership |
Susan Morrison | EVP & Chief Administrative Officer | Leadership |
Michael Michaud | VP, Research & Development | Leadership |
Arun Kumar | VP, Supply Chain | Leadership |
Ross Sylvia | VP, Marketing | Leadership |
Scott Kloos | Sr Director, Pump Manufacturing/test Engineering | Leadership |
Jeff Brown | VP, Program Management | Leadership |
Christina Sun | VP, Corporate Controller | Leadership |
Jessica Paul | Director, Learning And Talent Management | Leadership |
Virginia Lu | Director, Product Management / Advanced Technology Development | Leadership |
Elizabeth Ankeny | Sr. Director, Human Resources | Leadership |
Robert Perez | Director, Cyber Security Operations | Leadership |
Jeff Henrichs | Vice President Of IT Platforms | Leadership |
Michael Gaudi | Head Of IT Operations/services, PMO And Governance | Leadership |
Joseph Schneider | Vice President Of Commercial Operations | Leadership |
Kim Richardson | VP Privacy, Chief Privacy Officer - Tandem Diabetes Care | Leadership |
Leigh Vosseller | EVP & CFO | Leadership |
231 more people are available in the full profile.
Complete people profiles for Capillary Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Capillary Biomedical
4 dated milestones of Capillary Biomedical across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Capillary Biomedical is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Debt – Conventional, of $1.5M.
- Exit Acquired by Tandem Diabetes.
Competitors of Capillary Biomedical
Capillary Biomedical has 3 listed competitors in our database, 3 of them funded. They include Dexcom, Livongo and Bigfoot Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| bigfootbiomedical.com | 2014 | Milpitas, United States | $214.51M | 133 | Developer of a closed-loop automated insulin delivery system |
Detailed competitors of Capillary Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as Capillary Biomedical (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Capillary Biomedical
Complete news archive for Capillary Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Capillary Biomedical
Capillary Biomedical was founded in 2014.
Capillary Biomedical is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Capillary Biomedical is a funded company, having raised a total of $3M across 4 funding rounds to date. The company's 1st funding round was a Seed of $100K, raised on May 2014.
Capillary Biomedical has 1,922 employees.
Capillary Biomedical was founded in 2014 and is based in Irvine, United States. The company operates in the biomedical sector, focusing on devices for diabetes management. A small implant is placed under the abdominal skin through an outpatient procedure, where glucose levels in interstitial fluid are measured optically using infrared spectrometry. Data is transmitted wirelessly to external receivers, mobile devices, or insulin pumps, allowing real-time monitoring of glucose trends.
Capillary Biomedical's top competitors include Dexcom, Bigfoot Biomedical and Livongo.
Capillary Biomedical has 10 investors. Key investors include Tandem Diabetes, HHS, Pasadena Angels, Helmsley Charitable Trust, and Cove Fund.
Yes. Capillary Biomedical was acquired by Tandem Diabetes in July 2022.